Physician profile
Luis Scheker
NPI 1407840770
$5,842,217.04
in general payments reported to CMS, 2019-2025
3 companies · $877K in 2025
The $877K reported for 2025 was more than what 99% of Surgery of The Hand (Plastic Surgery) providers received nationally (typical 2025 total: $312).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $861K · 2020: $736K · 2021: $787K · 2022: $1.1M · 2023: $334K · 2024: $1.2M · 2025: $877K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.9M · Consulting Fee: $388K · Travel and Lodging: $138K · Food and Beverage: $20K · Gift: $5,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,854,239.50 |
| Consulting Fee | $388,000.00 |
| Travel and Lodging | $138,448.23 |
| Food and Beverage | $20,018.07 |
| Gift | $5,234.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aptis Medical, LLC | $5,840,723.07 | 2019-2025 | Aptis Druj, Scheker Druj |
| Synthes Gmbh | $750.00 | 2020 | |
| Trimed, INC. | $743.97 | 2024-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$30,954,096.31 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Scheker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.